Why is "Arsenic trioxide" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-24 02:06:17
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Arsenic trioxide is the inorganic compound with the formula As4O6. As an industrial chemical, its major uses include the manufacture of wood preservatives, pesticides, and glass. For medical purposes, it is sold under the brand name Trisenox among others when used as a medication to treat a type of cancer known as acute promyelocytic leukemia. For this use it is given by injection into a vein.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
FDA Grants Fast Track Status to Oral Arsenic Trioxide for APL - Hematology Advisor
-
FDA Fast-Tracks Oral Arsenic Trioxide Agent for Rare AML Subtype - Targeted Oncology
-
New Arsenic Trioxide Agent Earns FDA Fast Track Designation in AML Subtype - CancerNetwork
-
All-Trans Retinoic Acid and Arsenic Trioxide in High-Risk Acute Promyelocytic Leukemia - The ASCO Post
-
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia - Nature
-
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia - The New England Journal of Medicine
-
In silico mechanisms of arsenic trioxide-induced cardiotoxicity - Frontiers
-
Oral arsenic trioxide for leukemia has a 97% cure rate: Hong Kong's prescription medicine enters international arena - Medical Xpress
-
Maximizing arsenic trioxide's anticancer potential: Targeted nanocarriers for solid tumor therapy - ScienceDirect.com
-
Arsenic trioxide consolidation in APL - The Lancet
-
Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα–JNK pathway | Cancer Gene Therapy - Nature
-
An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications - Nature
-
Immunological consequences of arsenic trioxide-induced necrosis - Nature
-
Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup - Nature
-
Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in pancreatic cancer - Nature
-
Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma - Nature
-
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse | Cell Death & Disease - Nature
-
Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment - Nature
-
Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis - Nature
-
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I | Cell Death & Disease - Nature
-
Arsenic trioxide regulates DYNAP through hsa-mir-573 and inhibits the proliferation of laryngeal cancer - Nature
-
Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex - Nature
-
Trial of Arsenic Trioxide Finds the Drug is Safe and Effective as a Short-Course Treatment for Lupus - Lupus Foundation of America
-
Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway - Nature
-
Arsenic Trioxide and Chemotherapy Quality of Life Outcomes in Acute Promyelocytic Leukemia - Cancer Nursing Today
-
Dr Gill on the Evaluation of Oral Arsenic Trioxide Plus ATRA/Ascorbic Acid in APL - OncLive
-
EU patent given to arsenic trioxide, aiming to treat RRMS - Multiple Sclerosis News Today
-
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial) - Nature
-
FDA Approves Arsenic Trioxide for Promyelocytic Leukemia - OncLive
-
Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis - Nature
-
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial - The Lancet
-
The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening - Frontiers
-
FDA Approves Arsenic Trioxide With Tretinoin for First-Line Treatment of Acute Promyelocytic Leukemia - The ASCO Post
-
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia - The New England Journal of Medicine
-
Arsenic trioxide alters the differentiation of mouse embryonic stem cell into cardiomyocytes | Scientific Reports - Nature
-
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress - Nature
-
Arsenic trioxide (Trisenox) - Oncology Nurse Advisor
-
Infection-related pathway activation and vulnerability to arsenic trioxide in acute promyelocytic leukemia with TTMV::RARA - Nature
-
Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells - Nature
-
Harinder Gill, MD, MBBS, on Acute Promyelocytic Leukemia: Assessing the Use of Oral Arsenic Trioxide, Retinoic Acid, and Ascorbic Acid - The ASCO Post
-
Dr. Patricia L. Kropf on Decitabine and Arsenic Trioxide in AML and MDS - Targeted Oncology
-
Amneal Launches Arsenic Trioxide Injection – Generic for Trisenox - Pharmacy Times
-
All -trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells - Nature
-
Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies - Frontiers
-
Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial) - PNAS
-
Dr. Francesco Lo-Coco on Arsenic Trioxide in APL - OncLive
-
Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia - Nature
-
Clinical and Practical Data On Use of Retinoic Acid and Arsenic Trioxide in APL - OncLive
-
Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia - Nature
-
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study - Nature
-
Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond - Frontiers
-
ATRA Plus Arsenic Trioxide Feasible for Acute Promyelocytic Leukemia - Cancer Therapy Advisor
-
COG AAML1331 Trial Arsenic Trioxide and All-Trans Retinoic Acid in Pediatric Patients With APL - The ASCO Post
-
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide - The New England Journal of Medicine
-
Intracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse - Nature
-
All-Oral Regimen Feasible and Effective in Acute Promyelocytic Leukemia, Study Finds - The ASCO Post
-
Nexus Pharmaceuticals Receives FDA Approval for Arsenic Trioxide Injection in 10mg per 10mL Vial - BioSpace
-
RETRACTED ARTICLE: Arsenic album 30C exhibits crystalline nano structure of arsenic trioxide and modulates innate immune markers in murine macrophage cell lines - Nature
-
Gingival and localized alveolar bone necrosis related to the use of arsenic trioxide paste—Two case reports - ScienceDirect.com
-
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia - Wiley
-
Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma - Nature
-
Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology - Frontiers
-
Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage - Nature
-
Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity - Nature
-
EMA recommends approval for arsenic trioxide and fampridine generics - Generics and Biosimilars Initiative
-
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia - PNAS
-
Arsenic trioxide, a therapeutic agent for APL - Nature
-
Fresenius Kabi Introduces Leukemia Drug Arsenic Trioxide Injection in 10 mg per 10 mL vial - BioSpace
-
Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia - The New England Journal of Medicine
-
Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience - Nature
-
Opportunities for Trisenox® (arsenic trioxide) in the treatment of myelodysplastic syndromes | Leukemia - Nature
-
Increased erythropoietin level and reticulocyte count during arsenic trioxide therapy - Nature
-
A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients - Nature
-
Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines - Nature
-
Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells - Nature
-
A Gentler Standard for Acute Promyelocytic Leukemia in Kids - MedPage Today
-
Oversight board continues to push for permanent arsenic solution - Cabin Radio
-
Arsenic trioxide: What is it is and why it’s so dangerous - Global News
-
Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia - Nature
-
(+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo - Nature
-
Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia - ACP Journals
-
Generic Version of Trisenox Now Available - Medical Professionals Reference
-
Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice | Leukemia - Nature
-
Arsenic patent keeps drug for rare cancer out of reach of many - Nature
-
Oncology Letters - Spandidos Publications
-
Amneal intros generic Trisenox - Drug Store News
-
Breakthrough in blood cancer treatment: HKU develops first oral arsenic trioxide - The Standard (HK)
-
Nexus gets FDA nod for generic Trisenox - Drug Store News
-
Flexipharm Austrading launches Arsenic Trioxide Phebra for leukaemia - Chemist+Druggist
-
Top ISRO scientist claims he was poisoned with arsenic trioxide in 2017 - DNA India
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.